Blog | Veristat Insightful Perspectives

A Paradigm Shift in Monitoring Clinical Trials

What we know as work has experienced a major transformation. This shift and the changes it precipitated have affected how we now conduct and perform monitoring of clinical trials.


Read More

EMA Guidance on Management of Clinical Trials during COVID-19 Pandemic

Summary of Key Considerations Outlined in the Third Edition of the EMA Guidance


The European Medicines Agency (EMA) has now published its third version of the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic.  This guidance addresses the need for sponsors to change the execution of clinical trials during the global COVID-19 pandemic response. 

Read More

Evolving Risk-Based Monitoring to Improve Clinical Studies

An Interview with Dunya Botetzayas, RN, Senior Director of Clinical Monitoring at Veristat

Read More

What Matters Most in the Clinical Study Feasibility Process

Site Selection to Protocol Development: An Approach to the Feasibility Process

How does the site feasibility study process work at Veristat? 

Our process starts from the RFP stage. We usually send a feasibility questionnaire to the site prior to the study award, to get an in-depth assessment of feasibility at the RFP stage. 

Read More